REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharma Innovations Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: All Other Miscellaneous Food Manufacturing | Toilet Preparation Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Warehousing and Storage | Scientific Research and Development Services | Packaging and Labeling Services
Full name: Pharma Innovations Sp. z o.o. Profile Updated: September 27, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Pharma Innovations Sp. z o.o. is an enterprise in Poland, with the main office in Warsaw. It operates in the Pharmaceutical Preparation Manufacturing industry. The enterprise was incorporated on January 28, 2005. Pharma Innovations Sp. z o.o. currently employs Above 250 (2012) people. There was a total negative growth of 78.25% in Pharma Innovations Sp. z o.o.’s total assets over the same period.

Headquarters
Ul. Adama Mickiewicza 37/58
Warsaw; Mazowieckie; Postal Code: 01-625

Contact Details: Purchase the Pharma Innovations Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Pharma Innovations Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Pharma Innovations Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Pharma Innovations Sp. z o.o. report to view the information.
Incorporation Date:
January 28, 2005
Company Performance
Financial values in the chart are available after Pharma Innovations Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total Operating Revenue
-86.05%
Operating Profit
44.38%
EBITDA
42.39%
Net Profit/Loss for the Period
45.62%
Total Assets
-78.25%
Total Equity
-13.58%
Return on Equity (ROE)
-13.01%
Debt / Equity
14.02%
Quick Ratio
-0.08%
Cash Ratio
0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?